unknown
Stage
2
Investors
About
Edgewise Therapeutics is a biotech company focused on developing novel therapeutics for neurological diseases by targeting the outer mitochondrial membrane.
Explore Edgewise Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.